Kiromic Biopharma, Inc. Human Resources Contracts & Agreements
26 Contracts & Agreements
- Bonus & Incentive Agreements (1 contract)
- Consulting Agreements (5)
- Employment Agreements (15)
- Non-Competition Agreements (3)
- Separation Agreements (2)
- Executive Employment Agreement dated as of October 1, 2023 by and between Kiromic Biopharma, Inc. and Brian Hungerford (Filed With SEC on October 3, 2023)
- Separation Agreement between Daniel Clark and Kiromic BioPharma, Inc. dated December 27, 2022 (Filed With SEC on December 30, 2022)
- Executive Employment Agreement effective as of July 11, 2022, by and between Kiromic BioPharma, Inc. and Dr. Leonardo Mirandola (Filed With SEC on July 12, 2022)
- Form of Confidential Information, Inventions, Non-Solicitation and Non-Competition Agreement (Filed With SEC on June 27, 2022)
- First Amendment to Executive Employment Agreement effective as of May 10, 2022, by and between Kiromic BioPharma, Inc. and Daniel Clark (Filed With SEC on May 11, 2022)
- First Amendment to Executive Employment Agreement effective as of May 10, 2022, by and between Kiromic BioPharma, Inc. and Pietro Bersani (Filed With SEC on May 11, 2022)
- Confidential Information, Inventions, Non-Solicitation, and Non-Competition Agreement effective as of February 14, 2022, between Kiromic BioPharma, Inc. and Daniel Clark (Filed With SEC on February 16, 2022)
- Executive Employment Agreement effective as of February 14, 2022, by and between Kiromic BioPharma, Inc. and Daniel Clark (Filed With SEC on February 16, 2022)
- Modification to Employment Agreement effective as of February 9, 2022, by and between Kiromic BioPharma, Inc. and Scott Dahlbeck (Filed With SEC on February 16, 2022)
- Transition and Consulting Agreement effective as of February 9, 2022, by and between Kiromic BioPharma, Inc. and Gianluca Rotino (Filed With SEC on February 16, 2022)
- Confidential Information, Inventions, Non-Solicitation, and Non-Competition Agreement effective as of January 27, 2022 between Kiromic BioPharma, Inc. and Pietro Bersani (Filed With SEC on February 2, 2022)
- Executive Employment Agreement effective as of January 27, 2022 by and between Kiromic BioPharma, Inc. and Pietro Bersani (Filed With SEC on February 2, 2022)
- Separation Agreement dated as of December 6, 2021 between Kiromic Biopharma, Inc. and Ignacio Nunez (Filed With SEC on December 10, 2021)
- Executive Employment Agreement by and between the Company and Dr. Michael Ryan, effective as of July 1, 2021 (Filed With SEC on July 8, 2021)
- Executive Employment Agreement by and between the Company and Mr. Ignacio Nunez, effective as of June 7, 2021 (Filed With SEC on June 7, 2021)
- Employment Agreement, to be effective upon the initial public offering, between Kiromic BioPharma, Inc. and Maurizio Chiriva Internati (Filed With SEC on June 26, 2020)
- Employment Agreement, to be effective upon the initial public offering, between Kiromic BioPharma, Inc. and Gianluca Rotino (Filed With SEC on June 26, 2020)
- Employment Agreement dated January 1, 2020 between Kiromic BioPharma, Inc and Scott Dahlbeck (Filed With SEC on June 26, 2020)
- Employment Agreement, to be effective upon the initial public offering, between Kiromic BioPharma, Inc. and Tony Tontat (Filed With SEC on June 26, 2020)
- Kiromic, Inc. 2017 Equity Incentive Plan (Filed With SEC on May 11, 2020)
- Addendum to Consulting Agreement, dated August 1, 2019, between Kiromic, Inc. and Gianluca Rotino (Filed With SEC on May 11, 2020)
- Consulting Agreement, dated July 20, 2018, between Kiromic, Inc. and Gianluca Rotino (Filed With SEC on May 11, 2020)
- Addendum to Consulting Agreement, dated August 1, 2019, between Kiromic, Inc. and Scott Dahlbeck (Filed With SEC on May 11, 2020)
- Consulting Agreement, dated November 2, 2018, between Kiromic, Inc. and Scott Dahlbeck (Filed With SEC on May 11, 2020)
- Addendum to Employment Agreement, dated March 20, 2016, between Kiromic, Inc. and Maurizio Chiriva Internati (Filed With SEC on May 11, 2020)
- Employment Agreement, dated March 20, 2016, between Kiromic, Inc. and Maurizio Chiriva Internati (Filed With SEC on May 11, 2020)